These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15764962)

  • 1. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis.
    Nieuwkerk PT; Oort FJ
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):445-8. PubMed ID: 15764962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the predictive performance of adherence measures for virologic failure detection in people living with HIV: a systematic review and pairwise meta-analysis.
    Almeida-Brasil CC; Moodie EEM; Cardoso TS; Nascimento ED; Ceccato MDGB
    AIDS Care; 2019 Jun; 31(6):647-659. PubMed ID: 30516060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors.
    Maggiolo F; Ravasio L; Ripamonti D; Gregis G; Quinzan G; Arici C; Airoldi M; Suter F
    Clin Infect Dis; 2005 Jan; 40(1):158-63. PubMed ID: 15614706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
    AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients.
    Maggiolo F; Ripamonti D; Arici C; Gregis G; Quinzan G; Camacho GA; Ravasio L; Suter F
    HIV Clin Trials; 2002; 3(5):371-8. PubMed ID: 12407486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.
    Hart JE; Jeon CY; Ivers LC; Behforouz HL; Caldas A; Drobac PC; Shin SS
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):167-79. PubMed ID: 20375848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.
    Nieuwkerk PT; Sprangers MA; Burger DM; Hoetelmans RM; Hugen PW; Danner SA; van Der Ende ME; Schneider MM; Schrey G; Meenhorst PL; Sprenger HG; Kauffmann RH; Jambroes M; Chesney MA; de Wolf F; Lange JM;
    Arch Intern Med; 2001 Sep; 161(16):1962-8. PubMed ID: 11525698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of virologic failure in HIV-1-infected patients starting highly active antiretroviral therapy in Porto Alegre, Brazil.
    Tuboi SH; Harrison LH; Sprinz E; Albernaz RK; Schechter M
    J Acquir Immune Defic Syndr; 2005 Nov; 40(3):324-8. PubMed ID: 16249707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.
    Knobel H; Guelar A; Carmona A; Espona M; González A; López-Colomés JL; Saballs P; Gimeno JL; Díez A
    AIDS Patient Care STDS; 2001 Apr; 15(4):193-9. PubMed ID: 11359661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome.
    DeMasi RA; Graham NM; Tolson JM; Pham SV; Capuano GA; Fisher RL; Shaefer MS; Pakes GE; Sawyerr GA; Eron JJ
    Adv Ther; 2001; 18(4):163-73. PubMed ID: 11697019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy adherence and highly active antiretroviral therapy: comparison of three sources of information.
    Vincke J; Bolton R
    AIDS Patient Care STDS; 2002 Oct; 16(10):487-95. PubMed ID: 12437860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of HIV Virologic Failure Rates Between Patients with Variable Adherence to Three Antiretroviral Regimen Types.
    Gordon LL; Gharibian D; Chong K; Chun H
    AIDS Patient Care STDS; 2015 Jul; 29(7):384-8. PubMed ID: 26114665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
    Fairley CK; Permana A; Read TR
    HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.
    Swindells S; DiRienzo AG; Wilkin T; Fletcher CV; Margolis DM; Thal GD; Godfrey C; Bastow B; Ray MG; Wang H; Coombs RW; McKinnon J; Mellors JW;
    JAMA; 2006 Aug; 296(7):806-14. PubMed ID: 16905786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.
    Tuldrà A; Fumaz CR; Ferrer MJ; Bayés R; Arnó A; Balagué M; Bonjoch A; Jou A; Negredo E; Paredes R; Ruiz L; Romeu J; Sirera G; Tural C; Burger D; Clotet B
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):221-8. PubMed ID: 11115952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens.
    Gifford AL; Bormann JE; Shively MJ; Wright BC; Richman DD; Bozzette SA
    J Acquir Immune Defic Syndr; 2000 Apr; 23(5):386-95. PubMed ID: 10866231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors.
    Liu H; Miller LG; Hays RD; Golin CE; Wu T; Wenger NS; Kaplan AH
    J Acquir Immune Defic Syndr; 2006 Mar; 41(3):315-22. PubMed ID: 16540932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.
    Martin M; Del Cacho E; Codina C; Tuset M; De Lazzari E; Mallolas J; Miró JM; Gatell JM; Ribas J
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1263-8. PubMed ID: 18834323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.